# Edward Benthall

> Edward Benthall is a funding round investor at The Eden Trust backing 3D Technology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [The Eden Trust](https://shizune.co/investors/profile/the-eden-trust)
- Location: Torquay, United Kingdom
- Total investments: 2
- Last investment: Oct 2013
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/pub/edward-benthall/11/47/990

Edward Benthall is a funding round investor at The Eden Trust in Torquay focused on 3D Technology and Biotechnology. Edward Benthall is the Chairman at The Eden Trust. Edward Benthall attended University of Cambridge.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| 3D Technology | 1 | 50% |
| Biotechnology | 1 | 50% |
| Health Diagnostics | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PneumaCare | PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a numberof medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device.PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development laboratories at its design and manufacturing partner, Plextek.PneumaScan™ produces standard medical outputs for a broader portion of the population because it observes patients from a distance and does not impede the respiratory system as with current spirometer technology. Measuring from a distance means lower infection risk, less harm, reduced patient discomfort and minimal instrument running costs from having to replace or sterilise parts which have contacted the patient. | $1.3M |  | Oct 30, 2013 |  |
| PneumaCare | PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a numberof medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device.PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development laboratories at its design and manufacturing partner, Plextek.PneumaScan™ produces standard medical outputs for a broader portion of the population because it observes patients from a distance and does not impede the respiratory system as with current spirometer technology. Measuring from a distance means lower infection risk, less harm, reduced patient discomfort and minimal instrument running costs from having to replace or sterilise parts which have contacted the patient. | $2.5M |  | Aug 02, 2011 |  |

2 of 2 investments shown.

## Co-investors
- [Cambridge Angels group](https://shizune.co/investors/profile/cambridge-angels-group) — VC Fund, 2 deals together
- [Sud Investments](https://shizune.co/investors/profile/sud-investments) — VC Fund, 2 deals together
- [Charterhouse Capital Partners](https://shizune.co/investors/profile/charterhouse-capital-partners) — VC Fund, 1 deal together
- [Torteval Investments](https://shizune.co/investors/profile/torteval-investments) — VC Fund, 1 deal together
- [University of Cambridge Enterprise](https://shizune.co/investors/profile/university-of-cambridge-enterprise) — VC Fund, 1 deal together

## About The Eden Trust

VC Fund



1 contacts available at The Eden Trust.

| Name | Title | Profile |
| --- | --- | --- |
| Edward Benthall | Chairman | https://shizune.co/investors/profile/edward-benthall |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Edward Benthall invest in?

Edward Benthall invests primarily in 3D Technology, Biotechnology and Health Diagnostics startups, most often at Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Edward Benthall last invest?

The most recent investment recorded for Edward Benthall closed in Oct 2013. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co